{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:22:37Z","timestamp":1790356957781,"version":"4.1.0"},"reference-count":52,"publisher":"Elsevier BV","issue":"1-2","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Pharmaceutics"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/j.ijpharm.2018.02.045","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T22:46:19Z","timestamp":1520289979000},"page":"47-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system"],"prefix":"10.1016","volume":"542","author":[{"given":"Elodie","family":"Czuba","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mouhamadou","family":"Diop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carole","family":"Mura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Schaschkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Langlois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Bietiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romain","family":"Neidl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lien","family":"Virciglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Auberval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Julien-David","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Maillard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yves","family":"Frere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Marchioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Pinget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Sigrist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijpharm.2018.02.045_b0005","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1211\/0022357011776522","article-title":"Transport studies of insulin across rat jejunum in the presence of chicken and duck ovomucoids","volume":"53","author":"Agarwal","year":"2001","journal-title":"J. Pharm. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0010","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1002\/jps.2600810908","article-title":"Epithelial transport of drugs in cell culture. VII: effects of pharmaceutical surfactant excipients and bile acids on transepithelial permeability in monolayers of human intestinal epithelial (Caco-2) cells","volume":"81","author":"Anderberg","year":"1992","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0015","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/j.ejpb.2012.10.003","article-title":"Establishment of a triple co-culture in vitro cell models to study intestinal absorption of peptide drugs","volume":"83","author":"Antunes","year":"2013","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0020","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/1758-5996-6-130","article-title":"Metabolic and oxidative stress markers in Wistar rats after 2 months on a high-fat diet","volume":"6","author":"Auberval","year":"2014","journal-title":"Diab. Metab. Syndr."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0025","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1002\/(SICI)1520-6017(200004)89:4<429::AID-JPS1>3.0.CO;2-J","article-title":"Intestinal permeation enhancers","volume":"89","author":"Aungst","year":"2000","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0030","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1016\/j.addr.2013.04.006","article-title":"Oral delivery of proteins by biodegradable nanoparticles","volume":"65","author":"Bakhru","year":"2013","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0035","doi-asserted-by":"crossref","first-page":"4363","DOI":"10.1021\/mp500439c","article-title":"Mechanisms of nanoparticle internalization and transport across an intestinal epithelial cell model: effect of size and surface charge","volume":"11","author":"Bannunah","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0040","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2174\/0929866521666140805124403","article-title":"Functional characterisation and permeation studies of lyophilised thiolated chitosan xerogels for buccal delivery of insulin","volume":"21","author":"Boateng","year":"2014","journal-title":"Protein Pept. Lett."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0045","doi-asserted-by":"crossref","first-page":"381","DOI":"10.4103\/0110-5558.76436","article-title":"Mucoadhesive drug delivery system: an overview","volume":"1","author":"Boddupalli","year":"2010","journal-title":"J. Adv. Pharm. Technol. Res."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0050","doi-asserted-by":"crossref","first-page":"4635","DOI":"10.1016\/j.biomaterials.2006.04.026","article-title":"Nanoparticulate drug carriers based on hybrid poly(D, L-lactide-co-glycolide)-dendron structures","volume":"27","author":"Costantino","year":"2006","journal-title":"Biomaterials"},{"key":"10.1016\/j.ijpharm.2018.02.045_b0055","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/jps.20750","article-title":"Preparation of insulin loaded PLGA-Hp55 nanoparticles for oral delivery","volume":"96","author":"Cui","year":"2007","journal-title":"J. Pharm. Sci."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0060","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/fcp.12129","article-title":"Portal or subcutaneous insulin infusion: efficacy and impact on liver inflammation","volume":"29","author":"Dal","year":"2015","journal-title":"Fundam. Clin. Pharmacol."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0065","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.jconrel.2012.01.043","article-title":"PLGA-based nanoparticles: an overview of biomedical applications","volume":"161","author":"Danhier","year":"2012","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2018.02.045_b0070","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1016\/j.ijpharm.2015.05.065","article-title":"Design, characterisation, and bioefficiency of insulin-chitosan nanoparticles after stabilisation by freeze-drying or cross-linking","volume":"491","author":"Diop","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0075","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.ejpb.2004.02.008","article-title":"Investigation of the cytotoxicity and insulin transport of acrylic-based copolymer protein delivery systems in contact with Caco-2 cultures","volume":"57","author":"Foss","year":"2004","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0080","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.jcis.2010.04.011","article-title":"Adsorption of sodium dodecyl sulfate (SDS) at ZnSe and alpha-Fe2O3 surfaces: combining infrared spectroscopy and batch uptake studies","volume":"348","author":"Gao","year":"2010","journal-title":"J. Colloid Interface Sci."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0085","doi-asserted-by":"crossref","first-page":"3640","DOI":"10.3390\/ijms15033640","article-title":"An overview of poly(lactic-co-glycolic) acid (PLGA)-based biomaterials for bone tissue engineering","volume":"15","author":"Gentile","year":"2014","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0090","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.ijpharm.2013.05.025","article-title":"Toxicity of surface-modified PLGA nanoparticles toward lung alveolar epithelial cells","volume":"454","author":"Grabowski","year":"2013","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0095","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1111\/j.1365-2036.1987.tb00627.x","article-title":"Evaluation of an enteric-coated delayed-release 5-aminosalicylic acid tablet in patients with inflammatory bowel disease","volume":"1","author":"Hardy","year":"1987","journal-title":"Aliment. Pharmacol. Ther."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0100","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.ijpharm.2007.02.015","article-title":"Development of pH- and time-dependent oral microparticles to optimize budesonide delivery to ileum and colon","volume":"338","author":"Krishnamachari","year":"2007","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0105","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1166\/jnn.2006.411","article-title":"Preparation and characterization of insulin nanoparticles employing chitosan and poly(methylmethacrylate\/methylmethacrylic acid) copolymer","volume":"6","author":"Li","year":"2006","journal-title":"J. Nanosci. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0110","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/0022-1759(83)90097-2","article-title":"A fluorescence quenching technique using trypan blue to differentiate between attached and ingested glutaraldehyde-fixed red blood cells in phagocytosing murine macrophages","volume":"57","author":"Loike","year":"1983","journal-title":"J. Immunol. Meth."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0115","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.jconrel.2016.04.012","article-title":"Dual chitosan\/albumin-coated alginate\/dextran sulfate nanoparticles for enhanced oral delivery of insulin","volume":"232","author":"Lopes","year":"2016","journal-title":"J. Control. Release"},{"key":"10.1016\/j.ijpharm.2018.02.045_b0120","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2174\/1389201015666140915151319","article-title":"Intestinal uptake of insulin nanoparticles: facts or myths?","volume":"15","author":"Lopes","year":"2014","journal-title":"Curr. Pharm. Biotechnol."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0125","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/j.addr.2016.07.007","article-title":"Oral absorption of peptides and nanoparticles across the human intestine: opportunities, limitations and studies in human tissues","volume":"106","author":"Lundquist","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0130","first-page":"2207","article-title":"Novel PLGA-based nanoparticles for the oral delivery of insulin","volume":"10","author":"Malathi","year":"2015","journal-title":"Int. J. Nanomed."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0135","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.nano.2007.03.006","article-title":"Chitosan-coated PLGA nanoparticles for DNA\/RNA delivery: effect of the formulation parameters on complexation and transfection of antisense oligonucleotides","volume":"3","author":"Nafee","year":"2007","journal-title":"Nanomedicine"},{"issue":"12","key":"10.1016\/j.ijpharm.2018.02.045_b0140","first-page":"763","article-title":"Enhancing the oral bioavailability of peptides drugs by using chemical modification and other approaches","volume":"4","author":"Naibo Yin","year":"2014","journal-title":"Med. Chem."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0145","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.4155\/tde.12.120","article-title":"Towards the nasal delivery of insulin","volume":"3","author":"Nazar","year":"2012","journal-title":"Ther. Deliv."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0150","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1471-2121-7-20","article-title":"Development of a serum-free co-culture of human intestinal epithelium cell-lines (Caco-2\/HT29-5M21)","volume":"7","author":"Nollevaux","year":"2006","journal-title":"BMC Cell Biol."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0155","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1023\/A:1024470508758","article-title":"Visualization of insulin-loaded nanocapsules: in vitro and in vivo studies after oral administration to rats","volume":"20","author":"Pinto-Alphandary","year":"2003","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0160","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ijpharm.2010.07.041","article-title":"Bioadhesive nanoparticles of fungal chitosan for oral DNA delivery","volume":"398","author":"Plapied","year":"2010","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0165","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1530\/acta.0.1020420","article-title":"Differences in the hepatic and renal extraction of insulin and glucagon in the dog: evidence for saturability of insulin metabolism","volume":"102","author":"Polonsky","year":"1983","journal-title":"Acta Endocrinol. (Copenh)"},{"key":"10.1016\/j.ijpharm.2018.02.045_b0170","first-page":"171","article-title":"A physico-chemical approach to production of alginate beads by emulsification-internal ionotropic gelation","author":"Poncelet","year":"1998","journal-title":"Colloids Surf."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0175","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.ijpharm.2011.10.017","article-title":"Duodenum-specific drug delivery: in vivo assessment of a pharmaceutically developed enteric-coated capsule for a broad applicability in rat studies","volume":"422","author":"Reix","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0180","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.ijpharm.2012.08.024","article-title":"In vitro uptake evaluation in Caco-2 cells and in vivo results in diabetic rats of insulin-loaded PLGA nanoparticles","volume":"437","author":"Reix","year":"2012","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0185","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.ejpb.2009.09.001","article-title":"Surface-functionalized polymethacrylic acid based hydrogel microparticles for oral drug delivery","volume":"74","author":"Sajeesh","year":"2010","journal-title":"Eur. J. Pharm. Biopharm."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0190","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1166\/jbn.2009.022","article-title":"Insulin-loaded PLGA nanoparticles for oral administration: an in vitro physico-chemical characterization","volume":"5","author":"Santander-Ortega","year":"2009","journal-title":"J. Biomed. Nanotechnol."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0195","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1007\/s11095-007-9367-4","article-title":"Alginate\/chitosan nanoparticles are effective for oral insulin delivery","volume":"24","author":"Sarmento","year":"2007","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0200","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1021\/mp400507g","article-title":"Development of an advanced intestinal in vitro triple culture permeability model to study transport of nanoparticles","volume":"11","author":"Schimpel","year":"2014","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0205","doi-asserted-by":"crossref","first-page":"43","DOI":"10.15415\/jptrm.2013.11004","article-title":"Surfactants: pharmaceutical and medicinal aspects","volume":"1","author":"Sekhon","year":"2013","journal-title":"J. Pharm. Technol. Res. Manage."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0210","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1517\/17425247.1.1.141","article-title":"Particle uptake by Peyer's patches: a pathway for drug and vaccine delivery","volume":"1","author":"Shakweh","year":"2004","journal-title":"Expert Opin. Drug Deliv."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0215","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1021\/acsami.5b03555","article-title":"N-trimethyl chitosan chloride-coated PLGA nanoparticles overcoming multiple barriers to oral insulin absorption","volume":"7","author":"Sheng","year":"2015","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.ijpharm.2018.02.045_b0225","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3390\/md13041819","article-title":"Stability of chitosan-a challenge for pharmaceutical and biomedical applications","volume":"13","author":"Szymanska","year":"2015","journal-title":"Mar. Drugs"},{"key":"10.1016\/j.ijpharm.2018.02.045_b0230","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1007\/s11095-008-9800-3","article-title":"Methods for the preparation and manufacture of polymeric nanoparticles","volume":"26","author":"Vauthier","year":"2009","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0235","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1002\/smll.200901158","article-title":"Effect of surface properties on nanoparticle-cell interactions","volume":"6","author":"Verma","year":"2010","journal-title":"Small"},{"key":"10.1016\/j.ijpharm.2018.02.045_b0240","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1186\/1556-276X-7-299","article-title":"Novel preparation of PLGA\/HP55 nanoparticles for oral insulin delivery","volume":"7","author":"Wu","year":"2012","journal-title":"Nanoscale Res. Lett."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0245","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1089\/dia.2005.7.695","article-title":"Alternative delivery of insulin via eye drops","volume":"7","author":"Xuan","year":"2005","journal-title":"Diabetes Technol. Ther."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0250","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1023\/A:1012102522787","article-title":"In vitro permeability across Caco-2 cells (colonic) can predict in vivo (small intestinal) absorption in man\u2013fact or myth","volume":"14","author":"Yee","year":"1997","journal-title":"Pharm. Res."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0255","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ijpharm.2015.02.055","article-title":"Enteric-coated capsules filled with mono-disperse micro-particles containing PLGA-lipid-PEG nanoparticles for oral delivery of insulin","volume":"484","author":"Yu","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.ijpharm.2018.02.045_b0260","series-title":"Enteric-coated capsule containing cationic nanoparticles for oral insulin delivery","author":"Yu Qian","year":"2013"},{"key":"10.1016\/j.ijpharm.2018.02.045_b0265","first-page":"561","article-title":"Current status and perspective of research on PEG-PLGA","volume":"32","author":"Zhou","year":"2010","journal-title":"Zhonghua Zhong Liu Za Zhi"}],"container-title":["International Journal of Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318301261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0378517318301261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,2]],"date-time":"2019-02-02T04:09:44Z","timestamp":1549080584000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0378517318301261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5]]},"references-count":52,"journal-issue":{"issue":"1-2","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S0378517318301261"],"URL":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.02.045","relation":{},"ISSN":["0378-5173"],"issn-type":[{"value":"0378-5173","type":"print"}],"subject":[],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oral insulin delivery, the challenge to increase insulin bioavailability: Influence of surface charge in nanoparticle system","name":"articletitle","label":"Article Title"},{"value":"International Journal of Pharmaceutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijpharm.2018.02.045","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}